PolyMedix Inc. (PYMX.OB) Prepares for Trials in the Second Quarter 2009
With pharmaceutical products beginning to go off patent, smaller research firms addressing more common viruses and physical maladies are becoming more attractive opportunities for larger pharmaceutical and biotechnology companies. PolyMedix Inc., a development stage biotechnology company, works to develop products oriented toward life threatening acute disorders. Additionally, the company develops products that may hold substantial consumer oriented potential. As many larger pharmaceutical and biotechnology companies’ product pipe-lines are in need of replenishment, the company has the potential to become very profitable with its consumer oriented product line. It does develop products that hold great promise for life threatening disorders, but…